Show simple record

dc.contributor.authorNaden, Kristina
dc.date.accessioned2020-09-17T03:13:05Z
dc.date.available2020-09-17T03:13:05Z
dc.date.issued2020-07-09
dc.identifier.issn2396-9776
dc.identifier.urihttps://hdl.handle.net/10652/4985
dc.description.abstractPICO QUESTION: Is there sufficient evidence to show surgical fluid therapy delivered at the recommended 3 mL/kg/hour for cats and 5 mL/kg/hour for dogs leads to a better outcome compared with widely accepted rates of 10 mL/kg/hour for both cats and dogs? `CATEGORY OF RESEARCH QUESTION - Treatment THE NUMBER AND TYPE OF STUDY DESIGNS REVIEWED Five studies were appraised. Two of these were opinion pieces, with one non-comparative prospective study, one randomised controlled trial, and one case control study STRENGTH OF EVIDENCE Weak OUTCOMES REPORTED Currently there is limited evidence to show that the surgical fluid therapy recommendations made by the 2013 Journal of the American Animal Hospital Association guidelines (Davis et al., 2013) for cats and dogs lead to a better outcome than accepted fluid therapy rates used. Fluid overload in humans can cause long-term adverse effects, however the same effects have yet to be shown specifically in veterinary patients. CONCLUSION No evidence was found that provides strong, conclusive evidence that the 2013 recommendations by the American Animal Hospital Association and American Association of Feline Practitioners leads to a better outcome for both cats and dogs. The resulting research outlined below identifies a need to conduct clinical studies on the effects of fluid therapy on cats and dogs, and identify clear monitoring protocols to minimise and ideally avoid, fluid overload. When adequate, valid clinical studies have been carried out, this will provide sufficient information for the development of evidence-based recommended rates of fluid therapy for veterinary medicine, in a range of contextsen_NZ
dc.language.isoenen_NZ
dc.publisherRCVS Knowledge (Royal College of Veterinary Surgeons)en_NZ
dc.rightsThis work is licensed under a Creative Commons Attribution 4.0 International License. Authors of Knowledge Summaries submitted to RCVS Knowledge for publication will retain copyright in their work, and will be required to grant RCVS Knowledge a non-exclusive license of the rights of copyright in the materials including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the materials in all languages and all media throughout the world, and to license or permit others to do so.en_NZ
dc.subjectcats (Felis catus)en_NZ
dc.subjectdogs (Canis familiaris)en_NZ
dc.subjectsurgical fluid therapyen_NZ
dc.subjectdrug dosageen_NZ
dc.subjectveterinary drugsen_NZ
dc.subjectveterinary medicineen_NZ
dc.titleDevelopments in surgical fluid therapy rates in veterinary medicineen_NZ
dc.typeJournal Articleen_NZ
dc.date.updated2020-08-06T14:30:09Z
dc.rights.holderAuthoren_NZ
dc.identifier.doidoi:https://doi.org/10.18849/ve.v5i3.299en_NZ
dc.subject.marsden070710 Veterinary Pharmacologyen_NZ
dc.identifier.bibliographicCitationNaden, K. (2020). Developments in surgical fluid therapy rates in veterinary medicine. Veterinary Evidence, 5(3), 1-15. doi:https://doi.org/10.18849/ve.v5i3.299en_NZ
unitec.publication.spage1en_NZ
unitec.publication.lpage15en_NZ
unitec.publication.volume5en_NZ
unitec.publication.issue3en_NZ
unitec.publication.titleVeterinary Evidenceen_NZ
unitec.peerreviewedyesen_NZ
unitec.identifier.roms65027en_NZ
unitec.publication.placeLondon, United Kingdomen_NZ


Files in this item

Thumbnail

This item appears in

Show simple record